Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease
-
Published:2024-10
Issue:
Volume:68
Page:152521
-
ISSN:0049-0172
-
Container-title:Seminars in Arthritis and Rheumatism
-
language:en
-
Short-container-title:Seminars in Arthritis and Rheumatism
Author:
Di Donato StefanoORCID,
Huang Suiyuan,
Pauling John D,
Del Galdo Francesco,
Sabbagh Maya,
Khanna Dinesh,
Hughes Michael
Reference26 articles.
1. Raynaud's phenomenon—an update on diagnosis, classification and management;Pauling;Clin Rheumatol,2019
2. Hughes, M. & Shah. A.A. Other Secondary Causes. In: Wigley, F. M., Herrick, A. L. & Flavahan, N. A. (eds). Raynaud's phenomenon a guide to pathogenesis and treatment. Springer, Cham. https://doi.org/10.1007/978-3-031-52581-0_9 (2024).
3. Raynaud's phenomenon;Devgire;Br J Hosp Med (Lond),2019
4. Raynaud's Phenomenon;Wigley;NEJM,2016
5. Factors influencing patient decision-making concerning treatment escalation in Raynaud's phenomenon secondary to systemic sclerosis;Hughes;Arthrit Care Res (Hoboken),2021